Literature DB >> 18689391

Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs.

Bruce W Hollis1.   

Abstract

The number of assessments of circulating 25-hydroxyvitamin D [25(OH)D] for diagnostic purposes has increased significantly during the past 5 y. Over the years, techniques for quantifying 25(OH)D have increased and evolved. Some changes have been for the better and some have not. Most current methods appear to provide valid results as long as the operator of the given technique is properly trained and motivated. In addition, any laboratory that assesses circulating 25(OH)D for clinical diagnosis needs to participate in the Vitamin D External Quality Assessment Scheme. Finally, research has shown that circulating 25(OH)D is extremely stable in stored serum or plasma samples; this characteristic makes accurate, long-term epidemiologic studies of circulating 25(OH)D possible. In this article, I provide an overview of the techniques available for measuring 25(OH)D, compare these techniques with one another, and assess their clinical utility. I also briefly discuss the stability of 25(OH)D in biological media and present an overview of the Vitamin D External Quality Assessment Scheme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689391     DOI: 10.1093/ajcn/88.2.507S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  63 in total

1.  Parity and risk of hip fracture in postmenopausal women.

Authors:  M Kauppi; M Heliövaara; O Impivaara; P Knekt; A Jula
Journal:  Osteoporos Int       Date:  2010-10-06       Impact factor: 4.507

2.  Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study.

Authors:  Simerjot K Jassal; Michel Chonchol; Denise von Mühlen; Gerard Smits; Elizabeth Barrett-Connor
Journal:  Am J Med       Date:  2010-10-01       Impact factor: 4.965

3.  A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine.

Authors:  Debin Wan; Jun Yang; Bogdan Barnych; Sung Hee Hwang; Kin Sing Stephen Lee; Yongliang Cui; Jun Niu; Mitchell A Watsky; Bruce D Hammock
Journal:  J Lipid Res       Date:  2017-02-01       Impact factor: 5.922

4.  Associations between vitamin D levels and polycystic ovary syndrome phenotypes.

Authors:  Erin M Davis; Jennifer D Peck; Karl R Hansen; Barbara R Neas; LaTasha B Craig
Journal:  Minerva Endocrinol       Date:  2018-04-12       Impact factor: 2.184

Review 5.  Role of vitamin D in adults requiring nutrition support.

Authors:  Anastassios G Pittas; Ursula Laskowski; Luke Kos; Edward Saltzman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-10-29       Impact factor: 4.016

6.  Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis.

Authors:  Linda T Hiraki; Elizabeth V Arkema; Jing Cui; Susan Malspeis; Karen H Costenbader; Elizabeth W Karlson
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

Review 7.  Update in vitamin D.

Authors:  John S Adams; Martin Hewison
Journal:  J Clin Endocrinol Metab       Date:  2010-02       Impact factor: 5.958

8.  Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites.

Authors:  Jacqueline Chan; Karen Jaceldo-Siegl; Gary E Fraser
Journal:  Cancer Causes Control       Date:  2009-12-11       Impact factor: 2.506

9.  The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.

Authors:  D Lee Alekel; Marta D Van Loan; Kenneth J Koehler; Laura N Hanson; Jeanne W Stewart; Kathy B Hanson; Mindy S Kurzer; C Theodore Peterson
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

10.  Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women.

Authors:  Jeanne W Stewart; D Lee Alekel; Laura M Ritland; Marta Van Loan; Erik Gertz; Ulrike Genschel
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.